If you are looking for investing in a reputed company’s stocks then in this post “3 undervalued Stocks to invest in 2024“, I will suggest you 3 best companies in which you can buy their stocks to invest. These companies will make you rich by end of 2024. For this read the complete blog carefully.
3 undervalued Stocks to invest in 2024
In the ever-evolving landscape of investment opportunities, identifying a undervalued stocks with promising potential remains a very tough task for the investors. Through diligent analysis and consideration of market trends, these selections offer a blend of value, growth prospects, and resilience for investors seeking to diversify their portfolios and capitalize on untapped potential.
This article aims to headlines three such undervalued stocks worthy of consideration for investment in 2024. The name of the stocks are listed below, go to their official website analyze their market trends.
Must Read: 3 Cybersecurity Stocks to Buy in May 2024
1. BirlaSoft Limited
Birlasoft Limited is a global technology solutions company headquartered in India, providing IT consulting, outsourcing, and digital solutions to clients across various industries. Founded in 1995, it is part of the CK Birla Group, one of India’s leading business conglomerates.
The company emphasizes innovation and customer-centricity, leveraging emerging technologies like artificial intelligence, machine learning, and blockchain to drive business outcomes for its clients. The market cap value of this company is ₹ 17,255 Crore.
The current price of the stock is not much high which is only ₹ 625.00. According to statistics data the high and low price is estimated between ₹ 862.00 and ₹ 281.00 respectively.
| Aspects | Data |
| Current Price | ₹ 625.00 |
| Market Cap | ₹17,255 Crore |
| Stock P/E | 2.77 |
| ROCE | 30.1% |
| Book Value | ₹ 110 |
| ROE | 22.7 |
| High/Low | ₹ 862 / ₹281 |
| Dividend Yield | 0.54% |
| Face Value | ₹ 2.00 |
2. Angel One Limited
Angel One Limited is a prominent financial services company based in India. Established with the vision of democratizing access to financial markets, Angel One offers a comprehensive suite of services including online trading, investment advisory, wealth management, and financial products distribution.
With a strong presence across India and a growing footprint in international markets, Angel One continues to innovate and evolve, leveraging technology to enhance the accessibility, efficiency, and transparency of financial services. As a trusted partner for investors, Angel One remains dedicated to delivering value and fostering long-term financial success for its clients.
The market cap value of this company is ₹ 23,834 Crore. The current price of the stock is not much high which is only ₹ 2648.00. According to statistics data the high and low price is estimated between ₹ 3900.00 and ₹ 1181.00 respectively.
Must Read: Best Stocks for Beginners with Little Money
| Aspects | Data |
| Current Price | ₹ 2648.00 |
| Market Cap | ₹23,834 Crore |
| Stock P/E | 21.2 |
| ROCE | 38.7% |
| Book Value | ₹ 362 |
| ROE | 43.3% |
| High/Low | ₹ 3900 / ₹ 1181 |
| Dividend Yield | 1.52% |
| Face Value | ₹ 10.0 |
3. Gland Pharma Limited
Gland Pharma Limited is a leading Indian pharmaceutical company specializing in the development, manufacturing, and marketing of generic injectable drugs. Established in 1978, Gland Pharma has emerged as a global player in the pharmaceutical industry, renowned for its focus on complex injectables across various therapeutic segments such as oncology, anti-infectives, and critical care.
The company is known for its state-of-the-art manufacturing facilities, adherence to stringent quality standards, and commitment to innovation in drug delivery systems. Gland Pharma’s diverse product portfolio caters to both domestic and international markets, with a presence in over 60 countries worldwide.
Driven by a culture of continuous improvement and a relentless pursuit of excellence, Gland Pharma is dedicated to addressing unmet medical needs and improving patient outcomes. Through strategic partnerships, rigorous research and development, and a customer-centric approach, the company aims to make high-quality healthcare accessible and affordable to people around the globe.
The market cap value of this company is ₹ 27,803 Crore.
The current price of the stock is not much high which is only ₹ 1688.00. According to statistics data the high and low price is estimated between ₹ 2196.00 and ₹ 861.00 respectively.
Must Read: 3 Biotech Stocks Set to Double by 2030 : You should invest
| Aspects | Data |
| Current Price | ₹ 1688 |
| Market Cap | ₹27,803 Crore |
| Stock P/E | 40.1 |
| ROCE | 14.8% |
| Book Value | ₹ 504 |
| ROE | 10.9% |
| High/Low | ₹ 2196 / ₹ 861 |
| Dividend Yield | 0.00% |
| Face Value | ₹ 1.0 |
Conclusion,
The quest for undervalued stocks in 2024 presents an exciting opportunity for investors to uncover hidden gems in the market. Through careful analysis and consideration of various factors, including financial performance, industry trends, and growth potential, the three stocks highlighted in this article ‘3 undervalued Stocks to invest in 2024‘ offer compelling investment prospects.
As the market continues to evolve, staying vigilant and open to opportunities in undervalued stocks can be a rewarding strategy for investors looking to capitalize on potential gains in 2024 and beyond.
